Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2017

Sep 1, 2017

30870_dirs_2017-09-01_b49737b2-035a-447e-8fa9-e563609c2f2d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2017-09-01

Reporting Person: Blum Robert I (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-09-01 Common Stock S 100 $14.55 Disposed 79785 Direct
2017-09-01 Common Stock S 400 $14.6 Disposed 79385 Direct
2017-09-01 Common Stock S 100 $14.625 Disposed 79285 Direct
2017-09-01 Common Stock S 1200 $14.65 Disposed 78085 Direct
2017-09-01 Common Stock S 800 $14.675 Disposed 77285 Direct
2017-09-01 Common Stock S 1300 $14.7 Disposed 75985 Direct
2017-09-01 Common Stock S 300 $14.725 Disposed 75685 Direct
2017-09-01 Common Stock S 100 $14.75 Disposed 75585 Direct
2017-09-01 Common Stock S 200 $14.8 Disposed 75385 Direct
2017-09-01 Common Stock S 400 $14.9 Disposed 74985 Direct
2017-09-01 Common Stock S 100 $15.275 Disposed 74885 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2083 Indirect
Common Stock 2083 Indirect

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017.

F2: Shares held by The Bridget Blum 2003 Irrevocable Trust.

F3: Shares held by The Brittany Blum 2003 Irrevocable Trust.